Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-09

FDA Approved: PENCICLOVIR — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved the original application for penciclovir from Teva Pharmaceuticals USA, Inc. (ANDA212710), a generic topical antiviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penciclovir (Penciclovir)

Snippet

ORIG AP for PENCICLOVIR (PENCICLOVIR)